Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esha Sharma

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|September 8, 2017
A Botrytis cinerea KLP-7 Kinesin acts as a Virulence Determinant during Plant InfectionPamil Tayal, Sumit Raj, Esha Sharma, et al.
Frontline Gastroenterology|July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?Susanna Meade, Emma Routledge, Esha Sharma, et al.
Cureus|August 20, 2019
Hydrocortisone Reduces 28-day Mortality in Septic Patients: A Systemic Review and Meta-analysisWaqas J Siddiqui, Praneet Iyer, Ghulam Aftab, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switchRaphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2023
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative stateAnita Ng, Francesca Lovat, Andrew J Shih, et al.
Cancers|October 14, 2023
Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other StimuliAndrea N Mazzarello, Mark Fitch, Martina Cardillo, et al.
Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.
Gastrohep|December 28, 2020
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centreEsha Sharma, Susanna Meade, Francesca D'Errico, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|September 8, 2017
A Botrytis cinerea KLP-7 Kinesin acts as a Virulence Determinant during Plant InfectionPamil Tayal, Sumit Raj, Esha Sharma, et al.
Frontline Gastroenterology|July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?Susanna Meade, Emma Routledge, Esha Sharma, et al.
Cureus|August 20, 2019
Hydrocortisone Reduces 28-day Mortality in Septic Patients: A Systemic Review and Meta-analysisWaqas J Siddiqui, Praneet Iyer, Ghulam Aftab, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switchRaphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2023
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative stateAnita Ng, Francesca Lovat, Andrew J Shih, et al.
Cancers|October 14, 2023
Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other StimuliAndrea N Mazzarello, Mark Fitch, Martina Cardillo, et al.
Journal of Crohn'S & Colitis|April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK ExperienceSailish Honap, Desmond Chee, Thomas P Chapman, et al.
Gastrohep|December 28, 2020
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centreEsha Sharma, Susanna Meade, Francesca D'Errico, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 3